PARKERVISION INC Quarterly Common Stock, Shares, Issued from Q4 2010 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Parkervision Inc quarterly Common Stock, Shares, Issued history and growth rate from Q4 2010 to Q3 2024.
  • Parkervision Inc Common Stock, Shares, Issued for the quarter ending September 30, 2024 was 96.4M shares, a 11.1% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 96.4M +9.59M +11.1% Sep 30, 2024 10-Q 2024-11-13
Q2 2024 88.9M +3.38M +3.95% Jun 30, 2024 10-Q 2024-08-13
Q1 2024 88.4M +3.84M +4.54% Mar 31, 2024 10-Q 2024-05-14
Q4 2023 87.7M +6.44M +7.92% Dec 31, 2023 10-Q 2024-11-13
Q3 2023 86.8M +8.01M +10.2% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 85.5M +7.34M +9.4% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 84.5M +6.71M +8.62% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 81.2M +4.25M +5.53% Dec 31, 2022 10-K 2024-03-21
Q3 2022 78.8M +4.01M +5.37% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 78.2M +5.5M +7.57% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 77.8M +7.93M +11.3% Mar 31, 2022 10-Q 2022-05-11
Q4 2021 77M +18.4M +31.4% Dec 31, 2021 10-K 2023-03-28
Q3 2021 74.7M +22.8M +43.8% Sep 30, 2021 10-Q 2021-11-15
Q2 2021 72.7M +23.6M +48% Jun 30, 2021 10-Q 2021-08-13
Q1 2021 69.9M +26.8M +62.1% Mar 31, 2021 10-Q 2021-05-17
Q4 2020 58.6M +24.5M +71.8% Dec 31, 2020 10-K 2022-03-29
Q3 2020 52M +51.9M Sep 30, 2020 10-Q 2020-11-16
Q2 2020 49.1M +49.1M Jun 30, 2020 10-Q 2020-08-14
Q1 2020 43.1M +12.5M +40.7% Mar 31, 2020 10-Q 2020-05-15
Q4 2019 34.1M +5.42M +18.9% Dec 31, 2019 10-K 2021-03-31
Q3 2019 33.5K* -26.2M Sep 30, 2019 10-Q 2019-11-14
Q2 2019 31.7K* -25.8M Jun 30, 2019 10-Q 2019-08-14
Q1 2019 30.6M +6.83M +28.7% Mar 31, 2019 10-Q 2019-05-15
Q4 2018 28.7M +7.46M +35.1% Dec 31, 2018 10-K 2020-04-14
Q3 2018 26.2M +7.6M +40.9% Sep 30, 2018 10-Q 2018-11-14
Q2 2018 25.9M +8.1M +45.5% Jun 30, 2018 10-Q 2018-08-14
Q1 2018 23.8M +6.11M +34.5% Mar 31, 2018 10-Q 2018-05-15
Q4 2017 21.2M +8.04M +61% Dec 31, 2017 10-K 2019-04-01
Q3 2017 18.6M +5.5M +42% Sep 30, 2017 10-Q 2017-11-14
Q2 2017 17.8M +6.11M +52.3% Jun 30, 2017 10-Q 2017-08-14
Q1 2017 17.7M +6.23M +54.3% Mar 31, 2017 10-Q 2017-05-15
Q4 2016 13.2M +2.17M +19.7% Dec 31, 2016 10-K 2018-03-29
Q3 2016 13.1M -86.8M -86.9% Sep 30, 2016 10-Q 2016-11-15
Q2 2016 11.7M -86.1M -88.1% Jun 30, 2016 10-Q 2016-08-15
Q1 2016 11.5M -86.1M -88.2% Mar 31, 2016 10-Q 2016-05-16
Q4 2015 11M +1.3M +13.3% Dec 31, 2015 10-K 2017-03-30
Q3 2015 99.9M +2.82M +2.91% Sep 30, 2015 10-Q 2015-11-09
Q2 2015 97.8M +835K +0.86% Jun 30, 2015 10-Q 2015-08-10
Q1 2015 97.6M +1.06M +1.1% Mar 31, 2015 10-Q 2015-05-11
Q4 2014 9.72M -83.5M -89.6% Dec 31, 2014 10-K 2016-03-30
Q3 2014 97.1M +4.32M +4.65% Sep 30, 2014 10-Q 2014-11-10
Q2 2014 96.9M +8.3M +9.36% Jun 30, 2014 10-Q 2014-08-11
Q1 2014 96.5M +8.41M +9.55% Mar 31, 2014 10-Q 2014-05-12
Q4 2013 93.2M +10.3M +12.4% Dec 31, 2013 10-K 2015-03-16
Q3 2013 92.7M +9.88M +11.9% Sep 30, 2013 10-Q 2013-11-12
Q2 2013 88.6M +10.8M +13.9% Jun 30, 2013 10-Q 2013-08-08
Q1 2013 88.1M +20.4M +30.2% Mar 31, 2013 10-Q 2013-05-09
Q4 2012 82.9M +15.3M +22.7% Dec 31, 2012 10-K 2014-03-17
Q3 2012 82.9M +15.6M +23.2% Sep 30, 2012 10-Q 2012-11-14
Q2 2012 77.8M +18.6M +31.5% Jun 30, 2012 10-Q 2012-08-14
Q1 2012 67.7M +64.3M +1931% Mar 31, 2012 10-Q 2012-05-15
Q4 2011 67.6M +14.8M +28.1% Dec 31, 2011 10-K 2013-03-18
Q3 2011 67.3M Sep 30, 2011 10-Q 2011-11-14
Q2 2011 59.2M Jun 30, 2011 10-Q 2011-08-15
Q1 2011 3.33M Mar 30, 2011 10-K 2014-03-17
Q4 2010 52.8M Dec 31, 2010 10-K 2012-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.